» Articles » PMID: 33357445

Single-cell Landscape of the Ecosystem in Early-relapse Hepatocellular Carcinoma

Abstract

Hepatocellular carcinoma (HCC) has high relapse and low 5-year survival rates. Single-cell profiling in relapsed HCC may aid in the design of effective anticancer therapies, including immunotherapies. We profiled the transcriptomes of ∼17,000 cells from 18 primary or early-relapse HCC cases. Early-relapse tumors have reduced levels of regulatory T cells, increased dendritic cells (DCs), and increased infiltrated CD8 T cells, compared with primary tumors, in two independent cohorts. Remarkably, CD8 T cells in recurrent tumors overexpressed KLRB1 (CD161) and displayed an innate-like low cytotoxic state, with low clonal expansion, unlike the classical exhausted state observed in primary HCC. The enrichment of these cells was associated with a worse prognosis. Differential gene expression and interaction analyses revealed potential immune evasion mechanisms in recurrent tumor cells that dampen DC antigen presentation and recruit innate-like CD8 T cells. Our comprehensive picture of the HCC ecosystem provides deeper insights into immune evasion mechanisms associated with tumor relapse.

Citing Articles

Spatial immune scoring system predicts hepatocellular carcinoma recurrence.

Jia G, He P, Dai T, Goh D, Wang J, Sun M Nature. 2025; .

PMID: 40074893 DOI: 10.1038/s41586-025-08668-x.


Advancements in proteogenomics for preclinical targeted cancer therapy research.

Suo Y, Song Y, Wang Y, Liu Q, Rodriguez H, Zhou H Biophys Rep. 2025; 11(1):56-76.

PMID: 40070661 PMC: 11891078. DOI: 10.52601/bpr.2024.240053.


Patterns and outcomes of early and late recurrence after hepatectomy for hepatocellular carcinoma with microvascular invasion: a multicenter study in China.

Zhang X, Zhang T, Wu F, Li Z, Xiao Z, Yu Z Hepatol Int. 2025; .

PMID: 40063322 DOI: 10.1007/s12072-025-10802-w.


Analyze the Diversity and Function of Immune Cells in the Tumor Microenvironment From the Perspective of Single-Cell RNA Sequencing.

Ma L, Luan Y, Lu L Cancer Med. 2025; 14(5):e70622.

PMID: 40062730 PMC: 11891933. DOI: 10.1002/cam4.70622.


Development of a prognostic model for hepatocellular carcinoma based on microvascular invasion characteristic genes by spatial transcriptomics sequencing.

Mu X, Pan L, Wang X, Liu C, Li Y, Cai Y Front Immunol. 2025; 16:1529569.

PMID: 40051627 PMC: 11882567. DOI: 10.3389/fimmu.2025.1529569.